Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib + Lapatinib in Relapsed Malignant Glioma
NCT00350727Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2006
- Primary completion
- Dec 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of pazopanib, lapatinib in malignant glioma, sponsored by GSK. Started Dec 2006; status: completed.
02
Drugs
pazopaniblapatinib
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00350727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00350727.